StonvexLoading…
StonvexStonvexStonvexCore line items from AVO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-10-31 | Annual 2024 2024-10-31 | Annual 2023 2023-10-31 | Annual 2022 2022-10-31 |
|---|---|---|---|---|
Revenue | $1.39B | $1.23B | $953.90M | $1.05B |
Operating Income | $65.20M | $65.70M | $6.90M | $-37.20M |
Net Income | $37.70M | $36.70M | $-2.80M | $-34.60M |
EPS (Diluted) | $0.53 | $0.52 | $-0.04 | $-0.49 |
Total Assets | $983.00M | $971.50M | $914.80M | $879.50M |
Total Liabilities | $363.10M | $394.40M | $386.50M | $356.60M |
Cash & Equivalents | $64.80M | $58.00M | $42.90M | $52.80M |
Free Cash Flow OCF − CapEx | $37.20M | $61.20M | $-20.60M | $-26.00M |
Shares Outstanding | 70.57M | 70.91M | 70.73M | 70.67M |